(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
Cincinnati Children’s is the second highest recipient of research grants from the National Institutes of Health among pediatric hospitals. Our large research enterprise accounts for a third of our overall operating budget, and a third of our more than 13,000 employees are involved in research.
Within our more than 1 million square feet of research space, scientists conduct basic, translational, clinical and health services research.
The depth and breadth of our research program provides unusual opportunities for trainees in the Israel Exchange Program.
We foster an open environment, encouraging cross-disciplinary collaboration among researchers in all disciplines of medical sciences. The proximity of researchers to clinicians and to a large, well-characterized patient population provides a synergistic environment for research that advances care at the bedside.
Researchers and clinicians at Cincinnati Children’s innovate every day. The Center for Technology Commercialization (CTC) plays a key role in facilitating the translation of discoveries into improved clinical care for children. The CTC is responsible for advancing discoveries from the bench to the bedside.
CTC protects our innovations through patents; assists in further developing technologies through research partnerships; delivers products to the market through licensing and the creation of start-up companies. The CTC also encourages our researchers and clinicians to collaborate and share the results of their work with other institutions through the use of confidentiality agreements and material transfer agreements.
Cincinnati Children’s has a long history of connection with Israel, beginning with Dr. Albert Sabin, who discovered the Sabin oral polio vaccine at Cincinnati Children’s and later became president of Weizmann Institute.
More than 30 Israeli fellows have returned to Israel following training at Cincinnati Children’s, and we are proud to see their continued achievements and leadership roles.
Through the Cincinnati Children’s Israel Exchange Program, competitive grants are available for outstanding research post-doc applicants, including take-home grants to continue your research upon return to Israel and housing assistance during your time in Cincinnati.
Additional grants for collaborative research include:
Environment and Health Fund
Fulbright – The United States-Israel Educational Foundation
Gruss Lipper Family Foundation
Bikura Israel Science Foundation
Jane Coffin Childs Fund for Medical Research
Life Sciences Research Foundation
Rothschild Fellowships – Yad Hanadiv
Cincinnati Children’s and Ben-Gurion University of the Negev (BGU) are collaborating to fund the research and development of three pediatric-specific medical devices.
The collaboration, which pairs the medical expertise of Cincinnati Children’s physicians with the technical and engineering capabilities of BGU, started with nearly 80 unaddressed problems facing surgeons and physicians.
After reviewing these ideas and proposed solutions, 10 projects went through rigorous application cycles, thorough market analyses and review by internal and external stakeholders.
The three approved projects include a smart sensing catheter, a surfactant-delivery device and an image-guided needle insertion device. Each project is being led by a Cincinnati Children’s clinician or surgeon and a BGU engineer.
For more information on Cincinnati Children’s technology development, visit the Center for Technology Commercialization website.
Read news articles about the relationship between Cincinnati Children’s and Israel:
Nature Immunology article: Paired immunoglobulin-like receptor A is an intrinsic, self-limiting suppressor of IL-5-induced eosinophil development. The study is the result of the Israel Exchange Program at Cincinnati Children’s.
> Learn about research postdoc positions at Cincinnati Children's.
> Watch videos about graduate programs.
> The Center for Technology Commercialization (CTC) helps to translate discoveries into improved clinical care for children.
Our research contributions include:
• Sabin oral polio vaccine• First practical heart-lung machine• Clark oxygen electrode• Pioneering work in identification of congenital birth defects• Groundbreaking work in human surfactant replacement therapy• Rotarix rotavirus vaccine
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY:1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2016 Cincinnati Children's Hospital Medical Center